NEUROONE MEDICAL TECHNOLOGIES CORPORATION

Andere Sprachen NeuroOne Medical Technologies Corporation

Aktien

A3CMM6

US64130M2098

NMTC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 28.06.2024			% 5 Tage	% 1. Jan.
0,8 ^USD	+7,67 %		-2,14 %	-49,37 %

25.06.	NeuroOne® gibt den Abschluss der ersten Ablation am Menschen mit dem OneRF? Ablations-System	CI
20.06.	NeuroOne gibt bekannt, dass das OneRF Ablation System einen Verfahrenscode von CMS erhalten hat	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

NeuroOne Announces First in Human Ablations Completed with OneRF Ablation System	26.06.
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System	25.06.
NeuroOne® Announces First in Human Ablations Completed with OneRF? Ablation System	25.06.
NeuroOne Says OneRF Ablation System Gets Procedure Code From CMS	20.06.
NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation	20.06.
Neuroone Medical Technologies Corporation Receives Approval of ICD-10 Procedure Code for sEEG RF Ablation	20.06.
NeuroOne Medical Files Shelf Registration For $150 Million Securities Offering	31.05.
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	14.05.
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	14.05.
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14	10.05.
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology	10.04.
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes	09.04.
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.	04.04.
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System	26.03.
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	26.03.
NeuroOne to Participate in the 36th Annual Roth Conference	11.03.
NeuroOne® to Participate in the 36th Annual Roth Conference	08.03.
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	23.02.
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	13.02.
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	13.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen NeuroOne Medical Technologies Corporation

Aktien

A3CMM6

US64130M2098

NMTC

Andere Sprachen

Filter